Welcome to the Molecular Glue Drug Development Summit!
The Molecular Glue Drug Development Summit returns to Boston with fresh insights and opportunities!
With powerhouse partnerships lighting up the industry—like Biogen & Neomorph, Inc.’s groundbreaking $1.45B collaboration and Novartis joining forces with Monte Rosa Therapeutics for a $150M deal—the molecular glue space is certainly heating up.
There's no better time to secure your place at the 3rd Molecular Glue Drug Development Summit this January, where top innovators will be sharing first-hand insights into designing and optimizing molecular glues for previously undruggable targets!
You can expect 17+ deep dive case studies from the likes of Novartis, Pfizer, Neomorph, PhoreMost, and GSK, along with 9+ hours of interactive networking, this year is one you don’t want to miss!
Check out the official brochure here: https://ter.li/8g8kgk
Don’t forget you can save up to 20% off when you register with your colleagues!
